[Report on clinical trial of Lanitop].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D004338:Drug Combinations; D004077:Digoxin
Bericht über die klinische Prüfung von Lanitop.